Echothiophate Iodide

Echothiophate Iodide is a medicine used to treat high eye pressure (glaucoma). It works by making the eye's muscles relax, which helps lower the pressure inside the eye. It's a strong medicine, so it's usually only used when other treatments don't work.

Medication

What people taking Echothiophate Iodide report

Every report comes from a Lived member, sent anonymously.

Have you tried Echothiophate Iodide for Open-Angle Glaucoma?

NameHow it went

About Echothiophate Iodide

What It's For

Echothiophate iodide, sold in the US as Phospholine Iodide, is a prescription eye drop with two approved uses. The first is lowering raised pressure inside the eye (intraocular pressure, or IOP), as in some types of glaucoma. The second is accommodative esotropia, a form of crossed eyes, usually starting in early childhood, in which one or both eyes turn inward because of the effort the eyes make to focus. For accommodative esotropia, glasses that correct farsightedness are the usual first treatment. Echothiophate drops can be used as a short trial that helps show whether the eye turn is driven by focusing effort, and as a treatment in some children, with or without glasses. Echothiophate belongs to a group of medicines called cholinesterase inhibitors, and it is a long-acting one, which shapes both how well it works and the precautions it needs.

How It Works

Acetylcholine is a chemical messenger that tells muscles inside the eye to contract. Cholinesterase is the enzyme that normally clears acetylcholine away soon after it acts. Echothiophate blocks this enzyme for a long time, so acetylcholine's signal grows stronger and lasts longer. In the eye, that has three effects. The pupil becomes small, fluid drains out of the eye more easily, and eye pressure falls. The focusing muscle also responds more strongly, so a child with accommodative esotropia needs less focusing effort to see clearly, and less effort means less inward turning. Some of the drug reaches the rest of the body. After a few weeks of use, most people have lower cholinesterase levels in their blood. This is the reason for the interactions with anesthesia and with certain insecticides described below. Echothiophate is chemically related to organophosphate insecticides, which block the same enzyme.

Dosage & Administration

The current US product comes as a kit: a bottle of powder and a bottle of liquid that are mixed into a 0.125% eye drop solution. Before mixing, the kit is kept in the refrigerator. Once mixed, the drops are kept upright at room temperature, not refrigerated, and any solution left after 4 weeks is thrown away. For raised eye pressure, the usual schedule is one drop twice a day, in the morning and just before bed. Because the drug makes the pupil small, the bedtime dose (or the only dose, when once a day is enough) is timed so this matters less during waking hours. For esotropia in children, a trial usually starts with one drop in both eyes at bedtime, once a day, for two or three weeks. If the eyes straighten, the eye doctor lowers the schedule to the least frequent dosing that keeps them straight, often one drop every other day. Once a day is the usual maximum. After putting in a drop, press gently on the inner corner of the eye, next to the nose, for a minute or two. This keeps the medicine from draining into the nose and throat, where it can be absorbed into the body. Wipe away any extra drops with a tissue and wash your hands afterward.

Side Effects

Stinging, burning, watery eyes, eyelid twitching, red eyes and an ache around the brow are common. Distance vision can become blurry, because the drug pushes the eye to focus up close. Over long use, the lining of the eye can thicken and the tear ducts can become blocked. Some effects inside the eye need an eye exam to find. Small cysts can form on the iris (the colored part of the eye), more often in children, and if treatment continues they can grow large enough to block vision. They usually shrink when the drops are stopped or used less often. The drug can also contribute to clouding of the lens (cataract), stir up inflammation inside the eye, and occasionally raise eye pressure rather than lower it. Retinal detachment has been reported in a few adults, although a link to the drug has not been proven. Report any new or worsening vision problem to the eye doctor promptly, and contact the eye doctor the same day for sudden flashes of light, a shower of new floaters, or a shadow or curtain over part of your vision. When enough of the drug reaches the body, it can cause drooling, loss of bladder control, diarrhea, heavy sweating, muscle weakness or an irregular heartbeat. If any of these appear, stop the drops and contact the prescriber right away. Trouble breathing needs emergency care.

Interactions & Warnings

Before any surgery or procedure that could involve general anesthesia, tell the surgeon and anesthesia team that you use echothiophate, even if it is only an eye drop. Succinylcholine, a fast-acting muscle relaxant used during anesthesia, should be given only with great caution, if at all, to people using this drug, because the combination can cause dangerous breathing and heart problems. Echothiophate adds to the effects of other cholinesterase inhibitors. That group includes pyridostigmine (Mestinon), a tablet for the muscle-weakness disease myasthenia gravis, and donepezil (Aricept), a tablet for Alzheimer's disease, so anyone taking a medicine for myasthenia gravis or dementia should ask whether it belongs to this group. It also includes organophosphate and carbamate insecticides and pesticides, which can be absorbed through the skin or lungs. People who work with these chemicals should discuss it with their prescriber; wearing a mask, washing often and changing clothes during exposure can reduce the amount absorbed. The drops are not used during active inflammation inside the eye (uveitis or iritis), or by most people with angle-closure glaucoma who have not had an iridectomy (a small laser or surgical opening in the iris), because the drug can worsen the blockage. They are used cautiously, if at all, by people with asthma, a very slow heart rate, low blood pressure, a recent heart attack, epilepsy, Parkinson's disease, a peptic ulcer or a past retinal detachment. The effects in pregnancy have not been studied, so it is used only if clearly needed. Little of the drug is expected to pass into breast milk, but the benefit of treatment still needs weighing against any possible effect on the infant. Anyone pregnant, planning pregnancy or breastfeeding should talk this through with the prescriber.

What to Expect

For raised eye pressure, the eye doctor checks the pressure at follow-up visits. If it does not stay at an acceptable level, the treatment is changed. Because the small pupil and up-close focusing can affect vision, many people find the bedtime dose easiest to live with. For esotropia, a response during the trial can begin within a few hours. Children on longer treatment need regular eye exams, partly to look for iris cysts. There is no set limit on how long treatment lasts while it is well tolerated, but the eye doctor often tries tapering the drops after about a year or two. If the eye turn returns, the eye doctor may suggest surgery. As with similar drops, the effect can occasionally fade after long use, and a break from treatment may restore it. Because echothiophate lowers cholinesterase throughout the body, make sure every doctor, dentist and pharmacist who treats you knows you use it, especially before any procedure.

Questions to Ask Your Doctor

  1. 1.Why is echothiophate a better choice for me (or my child) than glasses alone, other glaucoma drops or surgery?
  2. 2.How will we know it is working, and how often will eye pressure or eye alignment be checked?
  3. 3.Which changes in vision, or in how I feel overall, mean I should stop the drops and call you?
  4. 4.What should I tell my surgeon or anesthesia team, and how far ahead of a procedure?
  5. 5.Do my other medicines, health conditions or any work with insecticides make this drug riskier for me?

Last reviewed • Oct 2026

Educational content, not medical advice.